PER
Click for more information
5.00% 8.4¢ percheron therapeutics limited

PTC still has DMD drug Emflaza approved and marketed in the US...

  1. BoomCrashOffera
    720 Posts.
    lightbulb Created with Sketch. 210
    clock Created with Sketch.
    22/09/23
    15:00
    Post #: 69981099
    PTC still has DMD drug Emflaza approved and marketed in the US (3 more years left on Orphan status) as well as other less revenue significant drugs and a sizeable pipeline.

    FDA rejection of Translarna’s NDA application last year wouldn’t have helped though.
    Last edited by BoomCrashOffera: 22/09/23
    ANP Price at posting: 7.2¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢ 		Change
0.004(5.00%) 		Mkt cap ! $75.72M
Open High Low Value Volume
8.0¢ 8.4¢ 8.0¢ $26.89K 328.0K

Buyers (Bids)

No. Vol. Price($)
1 9602 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 58051 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.